B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity (2023) Lapuente D, Winkler TH, Tenbusch M Journal article, Review article Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage (2023) Nehlmeier I, Kempf A, Arora P, Cossmann A, Dopfer-Jablonka A, Stankov MV, Schulz S, et al. Journal article Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5 (2023) Hoffmann M, Arora P, Nehlmeier I, Kempf A, Cossmann A, Schulz S, Morillas Ramos G, et al. Journal article Immune responses to tumor-unrelated antigens might predict adverse effects in patients treated with anti-PD-1 immunotherapy (2022) Nuse B, Holland T, Mattner J Journal article, Editorial Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2 (2022) Arora P, Kempf A, Nehlmeier I, Graichen L, Schulz S, Cossmann A, Dopfer-Jablonka A, et al. Journal article, Editorial Compartmentalized immune responses and the local microbiota determine mucosal and systemic immunity against SARS-CoV-2 (2022) Buttenschön J, Vogt S, Mattner J Journal article, Editorial No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2 (2022) Arora P, Kempf A, Nehlmeier I, Graichen L, Winkler MS, Lier M, Schulz S, et al. Journal article Variant signaling topology at the cancer cell–T-cell interface induced by a two-component T-cell engager (2021) Kouhestani D, Geis M, Alsouri S, Bumm TGP, Einsele H, Sauer M, Stuhler G Journal article Recirculating IL-1R2+ Tregs fine-tune intrathymic Treg development under inflammatory conditions (2021) Nikolouli E, Elfaki Y, Herppich S, Schelmbauer C, Delacher M, Falk C, Mufazalov IA, et al. Journal article The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency (2021) Arora P, Rocha C, Kempf A, Nehlmeier I, Graichen L, Winkler MS, Lier M, et al. Journal article